Company intelligence / Profile preview
Bonac
Kurume City/Fukuoka City, Fukuoka Prefecture, Japaneasthamptonschools.org ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Bonac’s lead program TRK‑250/BNC‑1021 targets TGF‑β1 for idiopathic pulmonary fibrosis and has reached Phase 1. Other programs are in preclinical stages targeting neoplasms/cancer (BNC‑1251), COVID‑19 (BNC‑1322), macular dystrophy via renin receptor inhibition (BNC‑1601), and liver cirrhosis via MIR29B1 modulation (BNC‑1602). The company’s proprietary platform enables the development of stable single-strand long-chain nucleic acids suitable for inhaled delivery to the lungs. Early in vitro results show promise for their COVID-related candidate.
- Therapeutic areas
- PulmonologyInfectious DiseasesOphthalmologyGastroenterologyOncology
- Modalities
- Antisense oligonucleotideSmall interfering RNA
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Toray Industries (exclusive licensing agreement on TRK‐250/BNC‐10211)Fukuoka Prefectural Government (collaboration on COVID‐19 therapy development)
Beyond the preview
Go deeper on Bonac.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bonac.